Diagnosis and predictive molecular analysis of non-small-cell lung cancer in the Africa-Middle East region: challenges and strategies for improvement
Affiliations
Affiliations
- Ampath Pathology Laboratories and Department of Anatomical Pathology, University of Pretoria, South Africa. Electronic address: slavikt@ampath.co.za.
- Center of Pathology CHU Mustapha, Algiers, Algeria.
- American University of Beirut Medical Center, Riad El-Solh, Beirut, Lebanon.
- Kuwait Cancer Centre, Kuwait.
- Tripoli Medical Center, Tripoli, Libya.
- Kasr El Aini University Hospital, Garden City, Cairo, Egypt.
- AcuMed, Macclesfield, United Kingdom.
- National Guard Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
- Aberdeen Royal Infirmary, Aberdeen, Scotland, United Kingdom.
Abstract
The identification of tumor biomarkers provides information on the prognosis and guides the implementation of appropriate treatment in patients with many different cancer types. In non-small cell lung cancer (NSCLC), targeted treatment plans based on biomarker identification have already been used in the clinic. However, such predictive molecular testing is not currently a universally used practice. This is the case, in particular, in developing countries where lung cancer is increasingly prevalent. In September 2012 and November 2013, a committee of 16 lung cancer experts from Africa and the Middle East met to discuss key issues related to diagnosis and biomarker testing in NSCLC and the implementation of personalized medicine in the region. The committee identified current challenges for effective diagnosis and predictive analysis in Africa and the Middle East. Moreover, strategies to encourage the implementation of biomarker testing were discussed. A practical approach for the effective diagnosis and predictive molecular testing of NSCLC in these regions was derived. We present the key issues and recommendations arising from the meetings.
Keywords: ALK; Adenocarcinoma; Biomarker; EGFR; Molecular testing.
Similar articles
Murgu S, Colt H.Clin Lung Cancer. 2013 Nov;14(6):609-26. doi: 10.1016/j.cllc.2013.04.002.PMID: 24188629 Review.
Strategies for improving outcomes in NSCLC: a look to the future.
Stahel R, Peters S, Baas P, Brambilla E, Cappuzzo F, De Ruysscher D, Eberhardt WE, Felip E, Fennell D, Marchetti A, Paz-Ares L, Adjei AA.Lung Cancer. 2013 Dec;82(3):375-82. doi: 10.1016/j.lungcan.2013.08.025. Epub 2013 Sep 8.PMID: 24094287 Review.
The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.
Rossi G, Graziano P, Leone A, Migaldi M, Califano R.Semin Diagn Pathol. 2013 Nov;30(4):298-312. doi: 10.1053/j.semdp.2013.11.007. Epub 2013 Nov 13.PMID: 24342286 Review.
Toffart AC, Timsit JF, Couraud S, Merle P, Moro-Sibilot D, Perol M, Mastroianni B, Souquet PJ, Girard N, Jeannin G, Romand P, Chatellain P, Vesin A, Brambilla C, Brambilla E.Lung Cancer. 2014 Feb;83(2):182-8. doi: 10.1016/j.lungcan.2013.12.003. Epub 2013 Dec 21.PMID: 24388706
Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M.Metabolism. 2015 Mar;64(3 Suppl 1):S16-21. doi: 10.1016/j.metabol.2014.10.027. Epub 2014 Oct 30.PMID: 25468140 Review.
Cited by
Van Christ Manirakiza A, Rubagumya F, Rugengamanzi E, Mukandekezi A, Beneyo J, Musoni M, Muvunyi TZ.JTO Clin Res Rep. 2022 Mar 1;3(4):100304. doi: 10.1016/j.jtocrr.2022.100304. eCollection 2022 Apr.PMID: 35369606 Free PMC article.
Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer.
Sun M, Song J, Zhou Z, Zhu R, Jin H, Ji Y, Lu Q, Ju H.Dis Markers. 2016;2016:3823121. doi: 10.1155/2016/3823121. Epub 2016 Jan 11.PMID: 26880855 Free PMC article.
Value of serum marker HE4 in pulmonary carcinoma diagnosis.
Tang QF, Zhou ZW, Ji HB, Pan WH, Sun MZ.Int J Clin Exp Med. 2015 Oct 15;8(10):19014-21. eCollection 2015.PMID: 26770527 Free PMC article.
CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.
Tang Z, Yu W, Zhang C, Zhao S, Yu Z, Xiao X, Tang R, Xuan Y, Yang W, Hao J, Xu T, Zhang Q, Huang W, Deng W, Guo W.Mol Oncol. 2016 Feb;10(2):317-29. doi: 10.1016/j.molonc.2015.10.015. Epub 2015 Nov 5.PMID: 26628108 Free PMC article.